WuXi Biologics (Cayman) Inc
HKEX:2269

Watchlist Manager
WuXi Biologics (Cayman) Inc Logo
WuXi Biologics (Cayman) Inc
HKEX:2269
Watchlist
Price: 17.46 HKD 0.46% Market Closed
Market Cap: 72.5B HKD
Have any thoughts about
WuXi Biologics (Cayman) Inc?
Write Note

Relative Value

The Relative Value of one WuXi Biologics (Cayman) Inc stock under the Base Case scenario is 51.84 HKD. Compared to the current market price of 17.46 HKD, WuXi Biologics (Cayman) Inc is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
51.84 HKD
Undervaluation 66%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
84
vs Industry
60
Median 3Y
11.3
Median 5Y
20.7
Industry
4.1
Forward
3.7
vs History
80
vs Industry
33
Median 3Y
41.8
Median 5Y
64.1
Industry
32.7
Forward
19.6
vs History
80
vs Industry
43
Median 3Y
28.8
Median 5Y
63.9
Industry
22.1
vs History
vs Industry
8
Median 3Y
-79.7
Median 5Y
-106.8
Industry
33.6
vs History
84
vs Industry
71
Median 3Y
4.8
Median 5Y
7.2
Industry
2.6
vs History
84
vs Industry
64
Median 3Y
10.9
Median 5Y
20.2
Industry
3.9
Forward
3.4
vs History
84
vs Industry
58
Median 3Y
24.8
Median 5Y
43.1
Industry
8.6
vs History
80
vs Industry
43
Median 3Y
38.6
Median 5Y
59
Industry
18.5
Forward
10.2
vs History
82
vs Industry
38
Median 3Y
38.6
Median 5Y
62.9
Industry
23.7
Forward
14.1
vs History
80
vs Industry
44
Median 3Y
27.8
Median 5Y
62.5
Industry
21.4
vs History
vs Industry
6
Median 3Y
-101.7
Median 5Y
-82.7
Industry
28.8
vs History
84
vs Industry
73
Median 3Y
4.1
Median 5Y
6.8
Industry
2.4

Multiples Across Competitors

Competitors Multiples
WuXi Biologics (Cayman) Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
72.5B HKD 4 25.9 16.1 16.1
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 455.6 4 876 1 538.7 3 279.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
202.3B USD 4.8 33 21.4 30.6
US
Danaher Corp
NYSE:DHR
166.6B USD 7.8 42.8 26.9 40.4
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.8B USD 6 30.1 22.4 26.1
US
IQVIA Holdings Inc
NYSE:IQV
36.3B USD 2.4 25.8 14.2 21.7
US
Mettler-Toledo International Inc
NYSE:MTD
27B USD 7.2 34 24.3 27.2
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.4 48.3 32.4 40.7
CN
WuXi AppTec Co Ltd
SSE:603259
162B CNY 4.2 20.1 14.6 14.6

See Also

Discover More
Back to Top